DrugNews Scholarships

DrugNews periodically offers scholarships to students entering different medical fields.

Top notch research on products you’re using
Updates & news on side effects and injuries
Medical & legal support for you

Who We Are

DrugNews was created to be the #1 consumer resource for drug research, development, safety and litigation news. As part of this, we support those who research the safety of medications or help develop new drug concepts.            

We’re proud to announce our scholarship programs for the 2015 Spring, Summer and Fall semesters! These awards target those students planning a career in drug research, or with family members affected by a permanent drug injury.            

The scholarships will award $1,000 to a deserving undergraduate student each semester.

In order to qualify, students must:

  • Be a U.S. citizen or permanent resident currently enrolled in an accredited college or university.
  • Have completed at least 15 hours of undergraduate course work towards their degree.
  • Write an essay and submit to DrugNews via email at info@drugnews.net along with contact information and transcript.

The essay should range from 400-600 words, and explain why you wish to pursue a career in drug research; or how the injury of a family member from a drug side effect has affected your educational goals.

Below are the deadline to apply:

  • Spring 2016 - December 31, 2015
  • Summer 2016 - April 30, 2016
  • Fall 2016 - July 31, 2016.

The DrugNews Scholarship

  • Must be a U.S. citizen or permanent resident currently enrolled in an undergraduate degree program with 15 hours completed.
  • Must have a minimum cumulative G.P.A. of 3.0.
  • Must submit an essay detailing why you are pursuing a career in drug research or how a family member’s drug injury has affected your education. Publish the essay on your University personal homepage and send us the link to that page. Feel free to reference DrugNews.net.
  • Award: $1,000


DrugNews is pleased to announce the recipient of our inaugural Summer Scholarship, Ms. Leah Osae. Leah is entering her Junior year at the University of North Carolina – Chapel Hill, with plans to graduate in 2017.

Leah is pursuing a BA in Chemistry with a minor in Biology, with the goal of completing her studies in pharmacogenomics and pharmacotherapy. She has a specialized interest in the treatment of cancer, Parkinson’s Disease, cystic fibrosis, and HIV/AIDS through more effective medications, as well as the development of safer drugs for all patients.

DrugNews applauds Leah’s efforts toward drug research and wishes her continued success in her endeavors.

DrugNews would like to thank all the applicants for our Fall 2015 Scholarship. The response this term was overwhelming and we were deeply moved by the many accounts of those affected by prescription drug complications. Many of you expressed how a drug side effect had altered your life or that of a loved one, leading you towards a career in research or patient care. We were also especially grateful for those who showed the dedication to care for children who were the victims of drug side effects before birth.

We are pleased to announce Rachel Koning as the winner of the Fall 2015 scholarship: Rachel is a sophomore at Davenport University who is pursuing a degree in nursing. Her ultimate goal is to be a pediatric hematology/oncology nurse, helping those children with the greatest need. Rachel draws her inspiration and dedication from her own personal experience with the dangers of toxic medication, which she encountered as a child. After a several-year battle to regain her strength and mobility, she is focused on helping children in the same way that others did for her.

Congratulations to Rachel and thank you to all of those who shared your stories with us. With your help, we are confident in the future of drug research and patient care.

Get in touch with us.

Call, email or live chat with us today to see how we can help.

call DrugNews.net
Need a quick answer? Call us!
email DrugNews.net
Reach out to us by email.
live chat with DrugNews
We are here to help now